Nav: Home

After the heart attack: Injectable gels could prevent future heart failure (video)

August 22, 2016

PHILADELPHIA, Aug. 22, 2016 -- During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells within the tissue. But the damage doesn't end after the crushing pain subsides. Instead, the heart's walls thin out, the organ becomes enlarged, and scar tissue forms. If nothing is done, the patient can eventually experience heart failure. But scientists now report they have developed gels that, in animal tests, can be injected into the heart to shore up weakened areas and prevent heart failure.

The researchers will present their work today at the 252nd National Meeting & Exposition of the American Chemical Society (ACS). ACS, the world's largest scientific society, is holding the meeting here through Thursday. It features more than 9,000 presentations on a wide range of science topics. A brand-new video on the research is available at http://bit.ly/ACShydrogels.

Heart attacks strike 750,000 people each year in the U.S., according to the American Heart Association. And more than 5 million U.S. residents are living with heart failure, with symptoms that progress from fatigue and shortness of breath to eventual death. "Heart failure is a huge problem, and few therapies are available for these patients," says Jason A. Burdick, Ph.D., leader of the study.

Treatments include lifestyle changes, medication, implants or heart transplants. Burdick, who is at the University of Pennsylvania (Penn), explains that these options often don't work well or, in the case of transplants, are hard to come by. So scientists are pursuing other treatment methods. For instance, researchers at other institutions have done animal studies in which they injected cells into the damaged section of the heart to try to repair damage. To prevent the cells from leaking out, those researchers embedded them in biodegradable "hydrogels" -- water-swollen networks of polymer chains with a consistency similar to Jell-OTM. But the scientists noticed something odd when they ran control experiments in which they injected the hydrogel without added cells: Some of the animals' hearts still showed improvement compared with untreated animals.

Based on those findings, a handful of labs are now experimenting with hydrogel treatments, including two materials that are in clinical trials. Neither is from Burdick's lab, but as he notes, "It's important we all keep moving forward to figure out how this therapy could be used, because it's different than any current treatment." In addition, different types of hydrogels could suit different patients' needs.

Some experimental heart attack treatments require surgery to open up the chest, but the two hydrogel materials already in clinical trials are injected into the damaged tissue through a long catheter inserted through the skin -- eliminating the need for open-chest surgery.

Burdick and his graduate student Christopher B. Rodell, in collaboration with Robert C. Gorman, M.D., also at Penn, are using this same minimally invasive technique in their own work. But his team has gone a step further by identifying properties that would be useful in treating heart attack patients and then designing hydrogels with those properties. For instance, his group developed a hydrogel that forms additional crosslinks between the polymer chains after injection. The resulting material is stiffer and lasts longer than a gel without these additional crosslinks and the gels in clinical trials.

In fact, Burdick's gel is unique among hydrogels in providing mechanical support to stabilize the damaged area. In sheep studies, this gel limits formation of scar tissue, thinning of the heart's walls and enlargement of the heart. By preserving the organ's size, the gels also reduce leakage of blood through the mitral valve. Together, these benefits maintain the heart's blood-pumping ability and could stave off heart failure.

The team's materials are based on hyaluronic acid (HA), a type of sugar molecule that occurs naturally in the body. The researchers modified the HA molecules by attaching adamantane and cyclodextrin groups to allow the gels to flow through catheters, and they added thiol and methacrylate groups to enable post-injection cross-linking to stiffen the hydrogel. Once the researchers finalize the hydrogel formulation and delivery method, they hope to partner with a catheter firm to bring a product to market. Burdick's team and other research groups are also designing hydrogels that contain drugs or cells that can repair heart tissue.
-end-
He acknowledges funding from the National Institutes of Health and the American Heart Association.

The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With nearly 157,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.

Note to journalists: Please report that this research is being presented at a meeting of the American Chemical Society.

Follow us: Twitter | Facebook

Title

Engineered injectable supramolecular hydrogels for myocardial applications

Abstract

Heart disease is a major clinical problem and post myocardial infarction (MI), left ventricular (LV) remodeling ensues and leads to geometric changes that result in dilation and thinning of the myocardial wall. This increases stress in the infarct and healthy tissue and can ultimately result in heart failure. Injectable biomaterials are being investigated to address this clinical problem, including to alter stresses in the infarct region when injected and to deliver biologics, such as stem cells and biomolecules. My laboratory is interested in a class of hydrogels based on the molecule hyaluronic acid (HA) and we have synthesized variations of HA macromers that form hydrogels with a range of mechanical properties and degradation (from a few weeks to stable over many months). This tunability in properties allows us to investigate how material properties (e.g., mechanics and degradation) influence the ability of injectable HA hydrogels to alter stress profiles and LV remodeling and to deliver therapeutic molecules (e.g., TIMP-3, to alter matrix remodeling within infarcts). Most recently, we have designed a class of shear-thinning and self-assembling hydrogels that can be used for the delivery of mechanical signals, as well as cells and therapeutics. Ultimately, these iterations on material design are teaching us what important signals are needed in these hydrogels towards the next generation of translatable therapeutics for cardiac repair.

American Chemical Society

Related Heart Failure Articles:

New hope for treating heart failure
Heart failure patients who are getting by on existing drug therapies can look forward to a far more effective medicine in the next five years or so, thanks to University of Alberta researchers.
Activated T-cells drive post-heart attack heart failure
Chronic inflammation after a heart attack can promote heart failure and death.
ICU care for COPD, heart failure and heart attack may not be better
Does a stay in the intensive care unit give patients a better chance of surviving a chronic obstructive pulmonary disease (COPD) or heart failure flare-up or even a heart attack, compared with care in another type of hospital unit?
Tissue engineering advance reduces heart failure in model of heart attack
Researchers have grown heart tissue by seeding a mix of human cells onto a 1-micron-resolution scaffold made with a 3-D printer.
Smoking may lead to heart failure by thickening the heart wall
Smokers without obvious signs of heart disease were more likely than nonsmokers and former smokers to have thickened heart walls and reduced heart pumping ability.
After the heart attack: Injectable gels could prevent future heart failure (video)
During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells in the heart.
Heart failure after first heart attack may increase cancer risk
People who develop heart failure after their first heart attack have a greater risk of developing cancer when compared to first-time heart attack survivors without heart failure, according to a study today in the Journal of the American College of Cardiology.
Scientists use 'virtual heart' to model heart failure
A team of researchers have created a detailed computational model of the electrophysiology of congestive heart failure, a leading cause of death.
Increase in biomarker linked with increased risk of heart disease, heart failure, death
In a study published online by JAMA Cardiology, Elizabeth Selvin, Ph.D., M.P.H., of the Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues examined the association of six-year change in high-sensitivity cardiac troponin T with incident coronary heart disease, heart failure and all-cause mortality.
1 in 4 patients develop heart failure within 4 years of first heart attack
One in four patients develop heart failure within four years of a first heart attack, according to a study in nearly 25,000 patients presented today at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure by Dr.

Related Heart Failure Reading:

Heart Failure: A Companion to Braunwald's Heart Disease
by Douglas L. Mann MD (Author), G. Michael Felker MD MHS FACC FAHA (Author)

Oxford Textbook of Advanced Heart Failure and Cardiac Transplantation (Oxford Textbooks in Cardiology)
by Michael Domanski (Editor), Mandeep R. Mehra (Editor), Marc Pfeffer (Editor)

The 4 Stages of Heart Failure
by Brian Jaski (Author)

Living Well with Heart Failure, the Misnamed, Misunderstood Condition
by Edward K. Kasper (Author), Mary Knudson (Author)

Heart Failure (Handbook of Experimental Pharmacology)
by Johann Bauersachs (Editor), Javed Butler (Editor), Peter Sandner (Editor)

Mechanical Circulatory Support in End-Stage Heart Failure: A Practical Manual
by Andrea Montalto (Editor), Antonio Loforte (Editor), Francesco Musumeci (Editor), Thomas Krabatsch (Editor), Mark S. Slaughter (Editor), Cristiano Amarelli (Editor)

Heart Failure: A Practical Guide for Diagnosis and Management (Oxford American Cardiology Library)
by Stuart Katz (Author), Ragavendra Baliga (Series Editor)

Heart Failure: A Comprehensive Guide to Pathophysiology and Clinical Care
by Howard Eisen (Editor)

HEART FAILURE: A Life Journey

Heart Failure
by Thomas Nelson

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Dying Well
Is there a way to talk about death candidly, without fear ... and even with humor? How can we best prepare for it with those we love? This hour, TED speakers explore the beauty of life ... and death. Guests include lawyer Jason Rosenthal, humorist Emily Levine, banker and travel blogger Michelle Knox, mortician Caitlin Doughty, and entrepreneur Lux Narayan.
Now Playing: Science for the People

#492 Flint Water Crisis
This week we dig into the Flint water crisis: what happened, how it got so bad, what turned the tide, what's still left to do, and the mix of science, politics, and activism that are still needed to finish pulling Flint out of the crisis. We spend the hour with Dr Mona Hanna-Attisha, a physician, scientist, activist, the founder and director of the Pediatric Public Health Initiative, and author of the book "What the Eyes Don't See: A Story of Crisis, Resistance, and Hope in an American City".